...
首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Platelet transfusion refractoriness associated with HPA-1a (Pl(A1)) alloantibody without coexistent HLA antibodies successfully treated with antigen-negative platelet transfusions.
【24h】

Platelet transfusion refractoriness associated with HPA-1a (Pl(A1)) alloantibody without coexistent HLA antibodies successfully treated with antigen-negative platelet transfusions.

机译:无抗原共存的HLA抗体的HPA-1a(P1(A1))同种抗体相关的血小板输注难治性已成功用抗原阴性的血小板输注治疗。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Alloimmune-mediated refractoriness to platelet transfusion is most commonly due to antibody to HLA antigens in multiply transfused or multiparous patients. Published reports of poor transfusion response due to antibodies to platelet-specific antigens are rare and often confounded by the presence of coexistent antibodies against HLA antigens. CASE REPORT: A case is presented of a multiparous woman with acute myelogenous leukemia whose sole cause of transfusion refractoriness was antibody to platelet antigen HPA-1a. She responded dramatically to HPA-1a-negative platelet transfusion. CONCLUSION: This case provides strong serologic and clinical evidence that platelet transfusion refractoriness may result from antibodies to platelet-specific antigens.
机译:背景:同种免疫介导的血小板输注难治性最常见的原因是多次输血或多胎患者的抗HLA抗原抗体。由于针对血小板特异性抗原的抗体引起的输血反应差的已发表的报道很少见,并且常常因存在针对HLA抗原的抗体而混淆。病例报告:有一例多发性急性髓性白血病的妇女,其输血难治性的唯一原因是血小板抗原HPA-1a的抗体。她对HPA-1a阴性的血小板输注反应显着。结论:该病例提供了强有力的血清学和临床证据,表明血小板输注难治性可能是针对血小板特异性抗原的抗体引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号